Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain

Pérez, Sebastián; Armando, Pedro; Guerra, Andrea C. Molina; Pallares, Mercè Marti; Martínez, Fernando Martínez

doi:10.1007/s11096-008-9267-7

Cited by 4 publications

(1 citation statement)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite proving that they can deliver effective screenings and interventions in chronic diseases [5][6][7] and being located in the heart of the community, there are no published studies to date that focus on community pharmacists identifying the level of glycemic control in the community -an impor-tant first step towards improving care. As such, the primary objective of the present study was to determine the level of glycemic control in communitydwelling patients with type 2 diabetes.…”

Section: Introductionmentioning

confidence: 99%

Glycemic Control in Community-Dwelling Patients with Type 2 Diabetes

2012

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Glycemic Control in Community-Dwelling Patients with Type 2 Diabetes

2012

View full text Add to dashboard Cite

How ineffective hypertension control in subjects treated with angiotensin-converting enzyme inhibitors is related to polymorphisms in the renin-angiotensin-aldosterone system

Morales-Suárez-Varela

Mansego

Martı́n-Escudero

et al. 2010

European Journal of Pharmaceutical Sciences

View full text Add to dashboard Cite

The EPIFARM Study: An Observational Study in 574 Community Pharmacies in Spain Characterizing Patient Profiles of Men Asking for Erectile Dysfunction Medication

Morales¹,

Ibáñez

Machuca³

et al. 2010

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction Community pharmacists may be an important first point of contact for erectile dysfunction (ED) patients, but to date there are no reports of the characteristics of men approaching pharmacists for ED advice or treatment. Aim To characterize the profiles of men with and without phosphodiesterase-5 inhibitors (PDE5i) prescription asking for ED treatment at the pharmacy. Methods A multicenter, observational, cross-sectional study was conducted in Spanish community pharmacies September–November 2008. Of men asking for ED advice or treatment, each investigator recruited one with and one without PDE5i prescription. Study pharmacists completed a questionnaire of patient demographic, clinical, and behavioural data including the Sexual Health Inventory for Men. Main Outcome Measures Demographic characteristics and responses to questionnaires. Results Five hundred and seventy-four pharmacists recruited 1,147 patients; 1,113 were included for analysis. There were no statistical differences between the groups regarding weight, hypertension, diabetes mellitus, hypercholesterolemia, dyslipidemia, depression, or stress. There were no statistical differences in severity of ED (P = 0.7892) or proportion of men without ED in each group (P = 0.5755). ED symptoms had been present for a mean of 26 months in both groups before first consultation with a healthcare professional. The visit to the pharmacy was the first discussion about ED for 60.2% of the nonprescription group, and 50% of those who had previously discussed ED had done so with a pharmacist in the first instance. In the nonprescription group, 85.1% of men asked for a PDE5i. Conclusions Many men approached a community pharmacist for ED treatment and those with and without a PDE5i prescription had an equivalent ED severity and comorbidity profile. Community pharmacists should be trained in current concepts underlying the diagnosis and management of ED to enable them to educate men and encourage them to seek further medical care, increasing the chance of early detection of undiagnosed comorbidities such as cardiovascular disease.

show abstract

Relationship between cardiovascular risk factors and high blood pressure by community pharmacists in Spain

Cited by 4 publications

References 33 publications

Glycemic Control in Community-Dwelling Patients with Type 2 Diabetes

Glycemic Control in Community-Dwelling Patients with Type 2 Diabetes

How ineffective hypertension control in subjects treated with angiotensin-converting enzyme inhibitors is related to polymorphisms in the renin-angiotensin-aldosterone system

The EPIFARM Study: An Observational Study in 574 Community Pharmacies in Spain Characterizing Patient Profiles of Men Asking for Erectile Dysfunction Medication

Contact Info

Product

Resources

About